Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...

Detailed price information for Structure Therapeutics Inc (GPCR-Q) from The Globe and Mail including charting and trades.

A UCLA-led international research collaboration has unveiled a new technology that may help scientists better understand how ...

Researchers have discovered a promising new approach to lung cancer treatment. A small molecule called AVJ16 selectively blocks the cancer-driving protein IGF2BP1, halting tumor growth in preclinical ...

Malaria remains a major global health burden, and the continued emergence of resistance to frontline therapies, including artemisinin-based combination ...

Gastrointestinal (GI) cancer is one of the major causes of cancer-related mortality worldwide. Colorectal, gastric, esophageal, liver and pancreatic cancer ...

SAN FRANCISCO, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biotechnology company advancing precision oncology through its ...

Two quantum computers and two supercomputers teamed up to break the record on the biggest molecule yet to be simulated using ...